ArticleOncoimmunology2025
FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer.
Oliver Kepp et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleOncoimmunology2025
Oliver Kepp et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.